Caitlin Raymond: Framing Donor Eligibility as Risk Assessment
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at the University of Wisconsin-Madison, shared on LinkedIn:
“Donor infectious disease eligibility sounds straightforward — until it isn’t. I just published a new post for trainees framing donor eligibility as risk assessment, not a checklist — the way boards expect you to understand it and the way it actually works in practice. In this post I cover:
- Why some pathogens get NAT, others don’t.
- Why some are tested once, others every donation.
- Why donor history still matters in the era of ultra-sensitive testing.
If you work in transfusion medicine, blood banking, pathology, or are studying for boards, this one’s meant to connect the dots between regulations, biology, and real-world decisions.”
Title: Board Prep: Overview of Donor Infectious Disease Eligibility
Author: Caitlin Raymond
Read the full article here.
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Apr 20, 2026, 00:07Karen Zohrabyan: Honored to Be Speaking at CSI Frankfurt 2026
-
Apr 19, 2026, 15:59Nour Al-Mozain: Why Stem Cell Collection Parameters Need Adjustment in SCD for Gene Therapy?
-
Apr 19, 2026, 15:42S. Kate Hartman: A Clinical Framework for Anemia, Bleeding, and Transfusion Decision-Making
-
Apr 19, 2026, 15:20CHAMPION-AF Demonstrated Better Freedom From Clinically Relevant Bleeding Events – Boston Scientific Cardiology
-
Apr 19, 2026, 14:37Jean-Jacques Mourad: Cohort Study Insights on Aspirin Use in Patients with Horton’s Disease
-
Apr 19, 2026, 14:36Francisco Ujueta: Pulmonary Embolism Care Doesn’t End at the Acute Phase
-
Apr 19, 2026, 14:35Flora Peyvandi: Marking the Beginning of a Future with Less Suffering on World Haemophilia Day
-
Apr 19, 2026, 14:34Chokri Ben Lamine: 50 High-Yield Pearls on Hemoglobin Cutoffs for Anaemia from WHO 2024 Guideline
-
Apr 19, 2026, 14:31Kate Iyore: Simple Explanation of Deep Vein Thrombosis and Pulmonary Embolism